AnaptysBio Inc buy UBS Group AG
Start price
13.05.26
/
50%
€54.40
Target price
13.05.27
-
Performance (%)
-6.40%
Price
08:10
?
Summary
This prediction is currently active. With a performance of -6.40%, the BUY prediction for AnaptysBio Inc by UBS_Group_AG is down slightly. This prediction currently runs until 13.05.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 3.018% | 3.018% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ANAB provided by MarketBeat